Latest news
Xenon Pharmaceuticals Q2 Earnings Call Highlights - TradingViewTradingView · Fri, 07 Aug 2026 20:04:17 GMTXenon Pharmaceuticals' Azetukalner NDA Filing Remains on Track After FDA Meeting, RBC Says - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 18:03:22 GMTXenon Pharmaceuticals Inc. Stock 12‑Month Price Target Raised to $81.21, Implies 26% Upside - TradingViewTradingView · Fri, 07 Aug 2026 17:20:34 GMTXenon Pharmaceuticals Q2 Loss Widens - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 21:35:31 GMTXenon Pharmaceuticals Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 21:01:41 GMTXenon Pharmaceuticals Inc. Q2 2026: Revenue $0 EPS $(1.11) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:35:07 GMTXenon Reports Q2 2026 Financial Results and Provides Business Update - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 20:01:00 GMTFMR LLC and Abigail Johnson report 9.9% Xenon Pharmaceuticals (XENE) holding - Stock TitanStock Titan · Thu, 06 Aug 2026 14:44:34 GMT